Literature DB >> 14500524

Expression of Cpgp40/15 in Toxoplasma gondii: a surrogate system for the study of Cryptosporidium glycoprotein antigens.

R M O'Connor1, K Kim, F Khan, H D Ward.   

Abstract

Cryptosporidium parvum is a waterborne enteric coccidian that causes diarrheal disease in a wide range of hosts. Development of successful therapies is hampered by the inability to culture the parasite and the lack of a transfection system for genetic manipulation. The glycoprotein products of the Cpgp40/15 gene, gp40 and gp15, are involved in C. parvum sporozoite attachment to and invasion of host cells and, as such, may be good targets for anticryptosporidial therapies. However, the function of these antigens appears to be dependent on the presence of multiple O-linked alpha-N-acetylgalactosamine (alpha-GalNAc) determinants. A eukaryotic expression system that would produce proteins bearing glycosylation patterns similar to those found on the native C. parvum glycoproteins would greatly facilitate the molecular and functional characterization of these antigens. As a unique approach to this problem, the Cpgp40/15 gene was transiently expressed in Toxoplasma gondii, and the expressed recombinant glycoproteins were characterized. Antisera to gp40 and gp15 reacted with the surface membranes of tachyzoites expressing the Cpgp40/15 construct, and this reactivity colocalized with that of antiserum to the T. gondii surface protein SAG1. Surface membrane localization was dependent on the presence of the glycophosphatidylinositol anchor attachment site present in the gp15 coding sequence. The presence of terminal O-linked alpha-GalNAc determinants on the T. gondii recombinant gp40 was confirmed by reactivity with Helix pomatia lectin and the monoclonal antibody 4E9, which recognizes alpha-GalNAc residues, and digestion with alpha-N-acetylgalactosaminidase. In addition to appropriate localization and glycosylation, T. gondii apparently processes the gp40/15 precursor into the gp40 and gp15 component glycopolypeptides, albeit inefficiently. These results suggest that a surrogate system using T. gondii for the study of Cryptosporidium biology may be useful.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500524      PMCID: PMC201096          DOI: 10.1128/IAI.71.10.6027-6034.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Optimized expression of green fluorescent protein in Toxoplasma gondii using thermostable green fluorescent protein mutants.

Authors:  K Kim; M S Eaton; W Schubert; S Wu; J Tang
Journal:  Mol Biochem Parasitol       Date:  2001-04-06       Impact factor: 1.759

Review 2.  Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii.

Authors:  D Soldati; J F Dubremetz; M Lebrun
Journal:  Int J Parasitol       Date:  2001-10       Impact factor: 3.981

Review 3.  Transport and trafficking: Toxoplasma as a model for Plasmodium.

Authors:  D S Roos; M J Crawford; R G Donald; L M Fohl; K M Hager; J C Kissinger; M G Reynolds; B Striepen; W J Sullivan
Journal:  Novartis Found Symp       Date:  1999

4.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  The immunodominant 17-kDa antigen from Cryptosporidium parvum is glycosylphosphatidylinositol-anchored.

Authors:  J W Priest; L T Xie; M J Arrowood; P J Lammie
Journal:  Mol Biochem Parasitol       Date:  2001-03       Impact factor: 1.759

Review 6.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 7.  Epidemiology of Cryptosporidium: transmission, detection and identification.

Authors:  R Fayer; U Morgan; S J Upton
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

8.  Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.

Authors:  H Charest; M Sedegah; G S Yap; R T Gazzinelli; P Caspar; S L Hoffman; A Sher
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

9.  Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody.

Authors:  A M Cevallos; N Bhat; R Verdon; D H Hamer; B Stein; S Tzipori; M E Pereira; G T Keusch; H D Ward
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

10.  Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum.

Authors:  J W Priest; J P Kwon; M J Arrowood; P J Lammie
Journal:  Mol Biochem Parasitol       Date:  2000-03-05       Impact factor: 1.759

View more
  15 in total

Review 1.  Toxoplasma gondii: the model apicomplexan.

Authors:  Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

2.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

3.  Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii.

Authors:  Roberta M O'Connor; Jane W Wanyiri; Boguslaw S Wojczyk; Kami Kim; Honorine Ward
Journal:  Mol Biochem Parasitol       Date:  2007-01-07       Impact factor: 1.759

Review 4.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 5.  Human immune responses in cryptosporidiosis.

Authors:  Anoli Borad; Honorine Ward
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

6.  Serum antibody responses to polymorphic Cryptosporidium mucin antigen in Bangladeshi children with cryptosporidiosis.

Authors:  Olivia Lai; Christopher Morris; Sabeena Ahmed; Mohammed Mahbubul Karim; Wasif Khan; Honorine Ward; Roberta O'Connor
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

7.  Determining the protein repertoire of Cryptosporidium parvum sporozoites.

Authors:  Sanya J Sanderson; Dong Xia; Helena Prieto; John Yates; Mark Heiges; Jessica C Kissinger; Elizabeth Bromley; Kalpana Lal; Robert E Sinden; Fiona Tomley; Jonathan M Wastling
Journal:  Proteomics       Date:  2008-04       Impact factor: 3.984

8.  Biochemical and functional characterization of CpMuc4, a Cryptosporidium surface antigen that binds to host epithelial cells.

Authors:  John Paluszynski; Zachary Monahan; Maura Williams; Olivia Lai; Christopher Morris; Patrick Burns; Roberta O'Connor
Journal:  Mol Biochem Parasitol       Date:  2014-03-29       Impact factor: 1.759

9.  Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro.

Authors:  Jane W Wanyiri; Patsharaporn Techasintana; Roberta M O'Connor; Michael J Blackman; Kami Kim; Honorine D Ward
Journal:  Eukaryot Cell       Date:  2009-01-23

10.  Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts.

Authors:  Jun Zou; Xiao-Xi Huang; Guang-Wen Yin; Ye Ding; Xian-Yong Liu; Heng Wang; Qi-Jun Chen; Xun Suo
Journal:  Parasit Vectors       Date:  2011-08-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.